Julia W. Gargano

9.4k citations

75 papers · 5.0k indexed · 5 hit papers · h-index 31

Epidemiology top 1%
Infectious Diseases top 1%
Surgery top 5%
Cardiology and Cardiovascular Medicine top 5%
Health top 1%

Co-authors: Mathew J. Reeves Lauri E. Markowitz Lynda D. Lisabeth Pamela W. Duncan George Howard Cheryl Bushnell Sara E. Oliver Mike Grotewiel
Topics: Cervical Cancer and HPV Research (28 papers)Genital Health and Disease (22 papers)Hepatitis B Virus Studies (17 papers)
Cited by: Aging Health Rehabilitation
Journals: Annals of Internal Medicine PLoS ONE JNCI Journal of the National Cancer Institute
Partner nations: United States Canada United Kingdom

In The Last Decade

Julia W. Gargano

73 papers receiving 4.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes

2008 942 citations Mathew J. Reeves, Cheryl Bushnell et al. The Lancet Neurology profile →
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

2020 394 citations Sara E. Oliver, Julia W. Gargano et al. profile →
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

2021 371 citations Julia W. Gargano, Megan Wallace et al. profile →
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018

2021 288 citations Julia W. Gargano, Rayleen M. Lewis et al. profile →
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021

2021 130 citations Karen R. Broder, Julia W. Gargano et al. profile →

Peers

Countries citing papers authored by Julia W. Gargano

Since Specialization

Citations

This map shows the geographic impact of Julia W. Gargano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia W. Gargano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia W. Gargano more than expected).

Fields of papers citing papers by Julia W. Gargano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia W. Gargano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia W. Gargano. The network helps show where Julia W. Gargano may publish in the future.

Co-authorship network of co-authors of Julia W. Gargano

This figure shows the co-authorship network connecting the top 25 collaborators of Julia W. Gargano. A scholar is included among the top collaborators of Julia W. Gargano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia W. Gargano. Julia W. Gargano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HPV vaccination among gay, bisexual, and other men who have sex with men aged 27–45 years in the United States is potentially Cost-saving 2025 ·Vaccine ·P. A. Clay,Lauri E. Markowitz,Sameer Vali Gopalani,Arden Baxter,Julia W. Gargano,Carla L. DeSisto,Virginia Senkomago,Donatus U. Ekwueme,(unknown),Harrell W. Chesson	0
2	High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018 2024 ·Human Vaccines & Immunotherapeutics ·(unknown),Rayleen M. Lewis,Troy D. Querec,Julia W. Gargano,Elizabeth R. Unger,Lauri E. Markowitz	6
3	A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States 2023 ·Vaccine ·Megan Wallace,Hannah G. Rosenblum,Danielle Moulia,Karen R. Broder,Tom T. Shimabukuro,Christopher A. Taylor,Fiona P. Havers,Sarah Meyer,Kathleen Dooling,Sara E. Oliver,Stephen C. Hadler,Julia W. Gargano	11
4	Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018 2022 ·Annals of Internal Medicine ·Hannah G. Rosenblum,Rayleen M. Lewis,Julia W. Gargano,Troy D. Querec,Elizabeth R. Unger,Lauri E. Markowitz	40
5	HPV type‐specific trends in cervical precancers in the United States, 2008 to 2016 2022 ·International Journal of Cancer ·Julia W. Gargano,Nancy McClung,Rayleen M. Lewis,Ina U. Park,Erin Whitney,Jessica L. Castilho,(unknown),Linda M. Niccolai,Monica Brackney,Emilio DeBess,(unknown),Nancy M. Bennett,Mary Scahill,Angela A. Cleveland,Troy D. Querec,Elizabeth R. Unger,Lauri E. Markowitz,(unknown)	19
6	Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies 2022 ·PLoS ONE ·Megan Wallace,Jennifer P. Collins,Heidi L. Moline,Ian D. Plumb,Monica Godfrey,Rebecca L. Morgan,Doug Campos‐Outcalt,Sara E. Oliver,Kathleen Dooling,Julia W. Gargano	6
7	HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring 2022 ·BMC Infectious Diseases ·Nancy McClung,(unknown),Julia W. Gargano,(unknown),Troy D. Querec,(unknown),Madisa Mine,Chelsea Morroni,Rebecca Luckett,Lauri E. Markowitz,Doreen Ramogola‐Masire	8
8	An Evaluation of Dose-Related HPV Vaccine Effectiveness Using Central Registries in Michigan 2021 ·Cancer Epidemiology Biomarkers & Prevention ·Julia W. Gargano,(unknown),Rachel Potter,Georgetta Alverson,Robert Swanson,Mona Saraiya,Lauri E. Markowitz,Glenn Copeland	6
9	Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination 2019 ·Papillomavirus Research ·(unknown),Pamela C. Hull,Yuwei Zhu,Julia W. Gargano,Lauri E. Markowitz,Angela A. Cleveland,(unknown),Ina U. Park,Erin Whitney,Edward F. Mitchel,Marie R. Griffin	10
10	Prevalence of Genital Human Papillomavirus in Males, United States, 2013–2014 2017 ·The Journal of Infectious Diseases ·Julia W. Gargano,Elizabeth R. Unger,Liu Gui,Martin Steinau,Elissa Meites,Eileen F. Dunne,Lauri E. Markowitz	65
11	Giardiasis and Subsequent Irritable Bowel Syndrome: A Longitudinal Cohort Study Using Health Insurance Data 2016 ·The Journal of Infectious Diseases ·Jolene H. Nakao,Sarah A. Collier,Julia W. Gargano	30
12	Giardiasis outbreaks in the United States, 1971–2011 2016 ·Epidemiology and Infection ·(unknown),Jonathan S. Yoder,L. Hannah Gould,Michele C. Hlavsa,Julia W. Gargano	67
13	Age-Group Differences in Human Papillomavirus Types and Cofactors for Cervical Intraepithelial Neoplasia 3 among Women Referred to Colposcopy 2012 ·Cancer Epidemiology Biomarkers & Prevention ·Julia W. Gargano,Rosane Nisenbaum,Daisy R. Lee,Mack T. Ruffin,Martin Steinau,Ira Horowitz,Lisa Flowers,Talaat S. Tadros,George Birdsong,Elizabeth R. Unger	19
14	Prevalence of Human Papillomavirus Types in Invasive Vulvar Cancers and Vulvar Intraepithelial Neoplasia 3 in the United States Before Vaccine Introduction 2012 ·Journal of Lower Genital Tract Disease ·Julia W. Gargano,Edward J. Wilkinson,Elizabeth R. Unger,Martin Steinau,Meg Watson,Youjie Huang,Glenn Copeland,Wendy Cozen,Marc T. Goodman,Claudia Hopenhayn,Charles F. Lynch,Brenda Y. Hernandez,Edward Peters,Maria Sibug Saber,Christopher Lyu,Lauren Sands,Mona Saraiya	56
15	A forward genetic screen in Drosophila implicates insulin signaling in age-related locomotor impairment 2009 ·Experimental Gerontology ·Melanie A. Jones,Julia W. Gargano,Devin Rhodenizer,Ian Martin,Poonam Bhandari,Mike Grotewiel	22
16	Infarction Involving the Insula and Risk of Mortality after Stroke 2009 ·Cerebrovascular Diseases ·Mark K. Borsody,Julia W. Gargano,Mathew J. Reeves,Bradley S. Jacobs	12
17	Polymorphisms in thrombophilia and renin-angiotensin system pathways, preterm delivery, and evidence of placental hemorrhage 2009 ·American Journal of Obstetrics and Gynecology ·Julia W. Gargano,Claudia Holzman,Patricia K. Senagore,Mary Lynne Reuss,Dorothy R. Pathak,Karen H. Friderici,Katherine Jernigan,Rachel Fisher	26
18	Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomesbreakdown → 2008 ·The Lancet Neurology ·Mathew J. Reeves,Cheryl Bushnell,George Howard,Julia W. Gargano,Pamela W. Duncan,(unknown),(unknown),Lynda D. Lisabeth	942
19	A proposed set of descriptors for functional senescence data 2005 ·Aging Cell ·Ian Martin,Julia W. Gargano,Michael S. Grotewiel	11
20	Rapid iterative negative geotaxis (RING): a new method for assessing age-related locomotor decline in 2005 ·Experimental Gerontology ·Julia W. Gargano,I. G. Martin,Poonam Bhandari,Mike Grotewiel	359

About Julia W. Gargano

Julia W. Gargano is a scholar working on Aging, Parasitology and Epidemiology, having authored 75 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (28 papers), Genital Health and Disease (22 papers) and Hepatitis B Virus Studies (17 papers). The work is most often cited by research in Aging (144 citations), Health (631 citations) and Rehabilitation (478 citations). Julia W. Gargano has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Mathew J. Reeves, Lauri E. Markowitz, Lynda D. Lisabeth, Pamela W. Duncan, George Howard, Cheryl Bushnell, Sara E. Oliver, Mike Grotewiel, Poonam Bhandari and Elizabeth R. Unger. Their work appears in journals such as Annals of Internal Medicine, PLoS ONE and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact